Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Javier
Contact Javier, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Minimal clinically important difference for cognitive scales in people with Parkinson’s disease with cognitive impairment
Abstract Cognitive impairment (CI) is a significant non-motor symptom of Parkinson’s disease (PD), necessitating effective assessment tools to evaluate treatment efficacy. Minimal Clinically Important Difference (MCID) thresholds provide critical benchmarks for interpreting cognitive intervention outcomes. This study establishes MCID values for PD Cognitive Rating Scale (PD-CRS), Scales for Outcomes in PD-Cognition (SCOPA-COG), and Montreal Cognitive Assessment (MoCA) in PD-CI.
Unraveling the genetic architecture of non-Huntington chorea: a biobank-scale study of rare variants and repeat expansions
|
Abstract Chorea can arise from genetic, metabolic, pharmacologic, and autoimmune causes. In clinical practice, however, non-genetic causes are rare. The most common genetic cause is a CAG repeat expansion in HTT, leading to Huntington’s disease (HD). Beyond HD, systematic studies have been lacking and many individuals with non-HD chorea remain without a molecular diagnosis.
By Fulya Akçimen, Monica Diez-Fairen, Ignacio Álvarez, Victor Puente Verified, spencer grant, Jorge Hernández-Vara, Marzieh Khani, Mariateresa Buongiorno, Félix Javier Jiménez-Jiménez, José A. G. Agúndez, Miquel Aguilar, Esther Cubo, Jesus Perez, Jesús Pérez, Javier Pagonabarraga, Nuria Caballol, Jinhui Ding, Elena García-Martín, Hortensia Alonso-Navarro, Yaroslau Compta, Carlos Cruchaga, Katrin Beyer, J. Raphael Gibbs, Andrew Singleton, Sara Bandrés-Ciga, Asuncion Avila
|
Nature
Verified
CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
1 Introduction Cognitive impairment is a common and disabling non-motor symptom in Parkinson's Disease (PD) that can occur at any stage of the disease [1]. Attention, working memory, and executive functions are the most prominently affected domains in the early stages, whereas language, visuospatial, and memory impairment generally appear in the later stages [2].
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Javier
Contact Javier, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack